Latest news
Recce Pharmaceuticals Issues 250,000 New Shares Under Corporations Act Exemption - TipRanksTipRanks · Tue, 04 Aug 2026 07:19:37 GMTRecce Pharmaceuticals Issues Cleansing Notice Following Share Issue - KalkineKalkine · Tue, 04 Aug 2026 07:04:52 GMTRecce Pharmaceuticals Files Cleansing Notice After Issuing 250,000 Shares on July 31, 2026 - Kalkine MediaKalkine Media · Tue, 04 Aug 2026 07:04:52 GMTRCE:ASX Announcement - Application for quotation of securities - RCE - 03 Aug 2026 - Market IndexMarket Index · Mon, 03 Aug 2026 06:29:05 GMTRecce Pharmaceuticals Issues 250,000 Shares at $0.375 Each for Corporate Advisory Services - KalkineKalkine · Mon, 03 Aug 2026 00:42:42 GMTRecce Pharmaceuticals Allocates 250,000 Shares at $0.375 Each to Settle Corporate Advisory Fees - Kalkine MediaKalkine Media · Mon, 03 Aug 2026 00:42:42 GMTRecce Pharmaceuticals to Quote 6,051,250 New Shares at 40 Cents Following Placement - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMTSuperbug Fighter Recce Pharmaceuticals (ASX:RCE) Steps Into the Global Biodefence Spotlight - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMT